Sanofi
- Country
- 🇫🇷France
- Ownership
- Public
- Employees
- 87.9K
- Market Cap
- $141.3B
- Website
- http://www.sanofi.com
- Introduction
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers
- Conditions
- Atrial Fibrillation
- Interventions
- Drug: Placebo (for Dronedarone)
- First Posted Date
- 2010-06-02
- Last Posted Date
- 2013-04-11
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 112
- Registration Number
- NCT01135017
- Locations
- 🇺🇸
Investigational Site Number 840021, Riverside, California, United States
🇺🇸Investigational Site Number 840030, Mesa, Arizona, United States
🇺🇸Investigational Site Number 840014, Dallas, Texas, United States
Canadian Outpatient VTE Management Registry
- Conditions
- Medical Prevention Therapy
- First Posted Date
- 2010-05-28
- Last Posted Date
- 2010-08-31
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 915
- Registration Number
- NCT01133002
- Locations
- 🇨🇦
Sanofi-Aventis Administrative Office, Laval, Canada
An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2010-05-25
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- Sanofi
- Registration Number
- NCT01130259
Food Effect Study on Pharmacodynamic and Bioavailability of Clopidogrel 300/75 mg in Healthy Subjects
- First Posted Date
- 2010-05-24
- Last Posted Date
- 2011-12-15
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 72
- Registration Number
- NCT01129271
- Locations
- 🇫🇷
Sanofi-Aventis Administrative Office, Paris, France
Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Pantoprazole 80 mg in Healthy Subjects
- First Posted Date
- 2010-05-24
- Last Posted Date
- 2011-12-15
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 66
- Registration Number
- NCT01129427
- Locations
- 🇺🇸
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States
Interaction Study of Clopidogrel 600/150 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects
- First Posted Date
- 2010-05-24
- Last Posted Date
- 2011-12-15
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 72
- Registration Number
- NCT01129414
- Locations
- 🇺🇸
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States
Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy Subjects
- First Posted Date
- 2010-05-24
- Last Posted Date
- 2011-12-15
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 72
- Registration Number
- NCT01129388
- Locations
- 🇺🇸
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States
Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy Subjects
- First Posted Date
- 2010-05-24
- Last Posted Date
- 2010-08-30
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 32
- Registration Number
- NCT01129063
- Locations
- 🇫🇷
Sanofi-Aventis Administrative Office, Paris, France
Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects
- First Posted Date
- 2010-05-24
- Last Posted Date
- 2011-12-15
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 72
- Registration Number
- NCT01129375
- Locations
- 🇺🇸
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States
Safety and Effectiveness Study of Insulin Glargine (LANTUS) Initiation and Titration in Patients With Type 2 Diabetes
- First Posted Date
- 2010-05-20
- Last Posted Date
- 2014-07-17
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 178
- Registration Number
- NCT01127269
- Locations
- 🇦🇷
Investigational Site Number 14, C.a.b.a., Argentina
🇦🇷Investigational Site Number 10, C.a.b.a., Argentina
🇦🇷Investigational Site Number 11, C.a.b.a., Argentina